HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chiara Lanzillotta Selected Research

Down Syndrome (Down's Syndrome)

1/2019Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome.
1/2018Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome.
1/2016Increased Mammalian Target of Rapamycin Signaling Contributes to the Accumulation of Protein Oxidative Damage in a Mouse Model of Down's Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chiara Lanzillotta Research Topics

Disease

10Alzheimer Disease (Alzheimer's Disease)
03/2024 - 01/2016
6Insulin Resistance
04/2023 - 10/2018
5Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 01/2016
5Cognitive Dysfunction
11/2021 - 01/2017
3Mitochondrial Diseases (Mitochondrial Disease)
11/2021 - 12/2018
3Down Syndrome (Down's Syndrome)
01/2019 - 01/2016
2Neoplasms (Cancer)
11/2020 - 01/2020
1Intellectual Disability (Idiocy)
01/2023
1Rett Syndrome (Rett's Disorder)
01/2023
1Proteostasis Deficiencies
01/2022
1Atrophy
01/2021
1Tauopathies
01/2021
1Trisomy (Trisomies)
01/2021
1Neoplasm Metastasis (Metastasis)
11/2020
1Starvation
11/2020
1Adenocarcinoma of Lung
11/2020
1Skin Neoplasms (Skin Cancer)
01/2020
1Genomic Instability
01/2020
1Carcinogenesis
01/2020
1Obesity
01/2019
1Fatty Liver
01/2019
1Dementia (Dementias)
12/2018
1Disease Progression
10/2018

Drug/Important Bio-Agent (IBA)

14Proteins (Proteins, Gene)FDA Link
04/2023 - 01/2016
6Insulin (Novolin)FDA Link
04/2023 - 01/2018
5Glucose (Dextrose)FDA LinkGeneric
04/2023 - 10/2018
3Amyloid (Amyloid Fibrils)IBA
01/2022 - 01/2016
3HexosaminesIBA
04/2021 - 10/2018
3biliverdin reductaseIBA
01/2020 - 01/2019
2AntioxidantsIBA
03/2024 - 11/2021
2Protein AggregatesIBA
01/2022 - 11/2021
2Phosphotransferases (Kinase)IBA
01/2021 - 11/2020
2ProteomeIBA
01/2021 - 01/2020
2Insulin ReceptorIBA
01/2020 - 01/2019
2Sirolimus (Rapamycin)FDA Link
01/2019 - 01/2018
1EnzymesIBA
03/2024
1Metformin (Glucophage)FDA LinkGeneric
01/2023
1ManganeseIBA
01/2021
1Glycine (Aminoacetic Acid)FDA LinkGeneric
11/2020
1Serine (L-Serine)FDA Link
11/2020
1Glycine Hydroxymethyltransferase (Serine Hydroxymethyltransferase)IBA
11/2020
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2020
1Amino AcidsFDA Link
11/2020
1Adenylate KinaseIBA
11/2020
1Adenosine Triphosphate (ATP)IBA
11/2020
1Adenosine Monophosphate (AMP)IBA
11/2020
1Biomarkers (Surrogate Marker)IBA
12/2018
1tau Proteins (tau Protein)IBA
12/2018
1Free RadicalsIBA
01/2016
1TOR Serine-Threonine KinasesIBA
01/2016

Therapy/Procedure

2Therapeutics
01/2023 - 01/2017